StockData
Altimmune, Inc. logo

Altimmune, Inc. (ALT) stock

ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.39−0.14 (-9.15%)

Close on Nov 18, 2026Market cap $270.38MP/E –Yield –

Altimmune price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Altimmune's price to sales ratio was 202.0× on Jan 31, 2023, against 93.0× a year earlier. Over the last 5 years it ranged from 0.3× to 294.6×, with a median of 51.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023202.0×−41.6
2022Dec 30, 2022243.7×+138.1
2021Dec 31, 2021105.5×+47.7
2020Dec 31, 202057.9×+54.1
2019Dec 31, 20193.7×+3.4
2018Dec 31, 20180.3×−3.1
2017Dec 29, 20173.5×–

More Altimmune figures

See a number that looks wrong?